Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-25-000003
Filing Date
2025-01-13
Accepted
2025-01-13 06:49:26
Documents
18
Period of Report
2025-01-12

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS f6-Kinsight.htm 6-K 10997
2 EX-99.1 frelease.htm EX-99.1 34288
3 EX-99.2 insightdeck.htm EX-99.2 1176
4 insightdeck1.jpg GRAPHIC 148344
5 insightdeck2.jpg GRAPHIC 366988
6 insightdeck3.jpg GRAPHIC 186431
7 insightdeck4.jpg GRAPHIC 238423
8 insightdeck5.jpg GRAPHIC 176710
9 insightdeck6.jpg GRAPHIC 164345
10 insightdeck7.jpg GRAPHIC 157739
11 insightdeck8.jpg GRAPHIC 177266
12 insightdeck9.jpg GRAPHIC 155687
13 insightdeck10.jpg GRAPHIC 152111
14 insightdeck11.jpg GRAPHIC 169160
15 insightdeck12.jpg GRAPHIC 184351
16 insightdeck13.jpg GRAPHIC 174550
17 insightdeck14.jpg GRAPHIC 128415
18 GRAPHIC image1.gif GRAPHIC 35096
  Complete submission text file 0002007191-25-000003.txt   3650393
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 25524714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)